Buyers pushing DVY towards its price target of $118.14; currently at $117.59

• IShares Select Dividend ETF's recent run now faces a challenge at $118.14
• The lower Bollinger Band® is currently at $131.82 while the higher band is at $136.15

Around $117.68, iShares Trust – iShares Select Dividend ETF can look to establish a new bullish phase beyond its 21 day Simple Moving Average. IShares Select Dividend ETF's lower Bollinger Band® is at $115.77, indicating that the market is oversold and fertile for new buyers. Despite this, iShares Select Dividend ETF's recent run now faces a major challenge as concentrated supply is likely found at $118.14 with price action currently 55 cents away.

Overall, looking at the technical analysis landscape, it seems iShares Select Dividend ETF might continue pointing upwards in the short term.

Concerning technical analysis and more specifically, trend indicators, around $134.91, Vanguard Mid-Cap Value ETF can look to establish a new bullish phase beyond its 50 day Simple Moving Average. Vanguard Mid-Cap Value ETF is alternating around the $134.57 Fibonacci resistance level. According to asset volatility analysis, Bollinger Band® analysis indicates that current price action is approaching the upper band at $136.15, thereby suggesting that Vanguard Mid-Cap Value ETF is becoming overvalued. A study of Vanguard Mid-Cap Value ETF's historical price actions shows Vanguard Mid-Cap Value ETF's run now faces a challenge at $135.55, which is only 56 cents away from the line. Overcoming it might send the company towards their next major resistance line— this will surely be interesting to follow.

Notwithstanding Vanguard Mid-Cap Value ETF's appreciation in recent days, the technical outlook suggests its bullish run is now fading.

Around $79.25, SPDR S&P Biotech ETF can look to establish a new bullish phase beyond its 50 day Simple Moving Average. SPDR S&P Biotech ETF is hovering above a known Fibonacci resistance level of $79.62. On the other hand, note that SPDR S&P Biotech ETF's run now faces a challenge at $81.43, which is only $1.23 away and will be interesting to follow.

Overall, looking at the technical analysis landscape, it seems SPDR S&P Biotech ETF might continue pointing upwards in the short term.

Upcoming fundamentals: United States ISM Manufacturing PMI (Apr) will be released tomorrow at 14:00 UTC.